Cyclic pamidronate therapy in children with osteogenesis imperfecta: Results of treatment and follow-up after discontinuation

Andiran, ZEYNEP; ALİKAŞİFOĞLU, AYFER; Gonc, Nazli; Ozon, ZEYNEP; KANDEMİR, NURGÜN; Yordarn, Nursen

doi:10.1515/jpem.2008.21.1.63

Cyclic pamidronate therapy in children with osteogenesis imperfecta: Results of treatment and follow-up after discontinuation

Copy For Citation

Andiran N. , ALİKAŞİFOĞLU A. , Gonc N., Ozon A. , KANDEMİR N. , Yordarn N.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.21, no.1, pp.63-72, 2008 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 21 Issue: 1
Publication Date: 2008
Doi Number: 10.1515/jpem.2008.21.1.63
Title of Journal : JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
Page Numbers: pp.63-72

Abstract

Background. Cyclic intravenous pamidronate treatment is widely used for symptomatic therapy of osteogenesis imperfecta (01). However, data after discontinuation are very limited.